Cistectomía radical, histerectomía con doble anexectomía y nefroureterectomía bilateral con extracción por vía transvaginal. Descripción y consideraciones específicas de la técnica quirúrgica

Juárez-Soto, A.; Arroyo-Maestre, José Miguel; Soto-Delgado, M.; Paz-Suárez, M. de; Beardo-Villar, P.; Arrabal-Polo, Miguel Ángel

doi:10.1016/j.acuro.2014.02.019

Cited by 3 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous studies recommend CUTE for panUCC patients, especially those with ESRD 7 8 9 10 18 19 . Patients with severe CKD or dialysis have been shown to manifest a higher risk of developing urothelial carcinoma 18 20 , and of experiencing tumor recurrence 4 21 22 .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients

Fang

Liu

et al. 2015

Sci Rep

View full text Add to dashboard Cite

The incidence of pan-urothelial cell carcinoma (panUCC), which refers to the presence of both bilateral (UTUC) and bladder tumor (BT), is relatively low. However, the profile of a panUCC cohort of patients remains to be elucidated. We reviewed the data of consecutive UTUC patients who received treatment at our center from 1999 to 2012. Overall, 45 patients were included in this study, with a median age of 64.5 years. Fourteen patients initially presented with unilateral UTUC, 11 initially with BT, and the remainder with multiple tumors. Patients with UTUC were more likely to manifest higher rates of muscle invasion and larger-sized tumors. Five patients were treated with complete urinary tract exenteration (CUTE), and most patients (73.3%) received combined management with conservative and radical surgery. After a median follow-up of 77 months, 18 patients (40%) died including 15 (33.3%) due to cancer. Higher tumor stage was the only risk factor predictive of worse survival. Nineteen patients experienced local recurrence after conservative surgery. This study indicated that PanUCC involves either synchronous or metachronous presentation of tumors with a high risk of tumor recurrence, progression, and dissemination after conservative surgery.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Several case reports found patients with both bilateral UTUC and BT 7 8 9 10 . Nguyen et al proposed the term pan-urothelial urothelial cell carcinoma (panUCC) to describe cancer in both upper urinary tracts and the bladder 11 .…”

mentioning

confidence: 99%

Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients

Fang

Liu

et al. 2015

Sci Rep

View full text Add to dashboard Cite

show abstract

Recidiva panurotelial en paciente con nefroureterectomía por tumor de células transicionales. Dilema terapéutico

Mukarukaka

Echevarría²

2022

Actas Urológicas Españolas

View full text Add to dashboard Cite

Panurothelial recurrence in a patient after nephroureterectomy for transitional cell carcinoma. A therapeutic dilema

Mukarukaka¹,

Echevarría²

2022

Actas Urológicas Españolas (English Edition)

View full text Add to dashboard Cite

Cistectomía radical, histerectomía con doble anexectomía y nefroureterectomía bilateral con extracción por vía transvaginal. Descripción y consideraciones específicas de la técnica quirúrgica

Cited by 3 publications

References 5 publications

Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients

Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients

Recidiva panurotelial en paciente con nefroureterectomía por tumor de células transicionales. Dilema terapéutico

Panurothelial recurrence in a patient after nephroureterectomy for transitional cell carcinoma. A therapeutic dilema

Contact Info

Product

Resources

About